Open | $9.400 |
Close | $9.530 |
Volume / Avg. | 449.042K / 778.950K |
Day Range | 9.080 - 9.601 |
52 Wk Range | 6.330 - 17.005 |
Market Cap | $737.694M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 3.46% |
Days to Cover | 4.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Accolade (NASDAQ: ACCD) through any online brokerage.
Other companies in Accolade’s space includes: GeneDx Hldgs (NASDAQ:WGS), Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI) and Privia Health Gr (NASDAQ:PRVA).
The latest price target for Accolade (NASDAQ: ACCD) was reported by Leerink Partners on Monday, February 26, 2024. The analyst firm set a price target for 16.00 expecting ACCD to rise to within 12 months (a possible 67.89% upside). 35 analyst firms have reported ratings in the last year.
The stock price for Accolade (NASDAQ: ACCD) is $9.53 last updated March 18, 2024 at 5:41 PM EDT.
There are no upcoming dividends for Accolade.
Accolade’s Q4 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Accolade.
Accolade is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.